AMA promotes benefits of “genetically improved” foodsBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7317.828/f (Published 13 October 2001) Cite this as: BMJ 2001;323:828
- Janice Hopkins
Although biotechnology has produced greatly improved, widely accepted drugs, there is still enormous controversy over the development of genetically modified crops that increase yields, lower costs, and offer better ways to feed the world, the director of science policy at the American Medical Association has said.
Speaking at a New York press briefing last week, Dr Barry David Dickinson, director of science policy for the American Medical Association, said that biotechnological advances had improved human insulin, growth hormone, monoclonal antibodies, tissue plasminogen activator (TPA), and more.
“Why, then, is there controversy over genetically modified crops?” he asked.
The seminar was funded by an unrestricted grant from the Council for Biotechnology Information, a group of six biotechnology firms and two trade associations. They included Aventis …
Log in using your username and password
Log in through your institution
Sign up for a free trial